Wed, Feb 02, 2022
In yet another episode of ‘Bhasin Ke Hasin Share’, Deepanshu Bhandari spoke to Sanjiv Bhasin, where he picked three stocks for high returns.
More >
Wed, Dec 22, 2021
Drug firm Zydus Cadila on Wednesday said it has received approval from the US health regulator to market Pimavanserin tablets, used in the treatment of certain mental disorders, in the American market.
Wed, Aug 11, 2021
EBIDTA for the quarter was Rs 933 cr, which was up by 18 per cent y-o-y and 16 per cent on q-o-q basis. The EBIDTA margin for the quarter was 23.2 per cent, an improvement of 140 basis points on the quarter-on-quarter (q-o-q), the company said in its exchange filing. EBIDTA margin for Q1FY21 was 22.5 per cent and 21.8 per cent in Q4FY21
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
